These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 8993088

  • 21. A pilot trial of gepirone vs. placebo in the treatment of cocaine dependency.
    Jenkins SW, Warfield NA, Blaine JD, Cornish J, Ling W, Rosen MI, Urschel H, Wesson D, Ziedonis D.
    Psychopharmacol Bull; 1992; 28(1):21-6. PubMed ID: 1609038
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 23. Minaprine and dose response in depression. An investigation of two fixed doses of minaprine compared with imipramine.
    Montgomery SA, Baldwin DS, Priest RG, Steinert J, Patel A, Herrington RN, Livingston HM.
    Pharmacopsychiatry; 1991 Sep; 24(5):168-74. PubMed ID: 1775522
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and tolerance of femoxetine and imipramine in the treatment of depressive states. A randomized, double-blind study.
    Suominen J, Tamminen T, Elosuo R, Manniche PM.
    Pharmacopsychiatry; 1988 Sep; 21(5):238-44. PubMed ID: 3067246
    [Abstract] [Full Text] [Related]

  • 25. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
    Nemeroff CB, Thase ME, EPIC 014 Study Group.
    J Psychiatr Res; 2007 Sep; 41(3-4):351-9. PubMed ID: 16165158
    [Abstract] [Full Text] [Related]

  • 26. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG, Pritchett YL, Kajdasz DK, Bauer M, Jain R, Russell JM, Walker DJ, Spencer KA, Froud DM, Raskin J, Thase ME.
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [Abstract] [Full Text] [Related]

  • 27. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 28. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS, Kobak KA, Jefferson JW, Mazza J, Greist JH.
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [Abstract] [Full Text] [Related]

  • 29. [Randomized double-blind comparative study of the efficacy and tolerance of medifoxamine and imipramine in depressed patients].
    Olié JP, Galinowski A, Lehert P, Lemonnier F, Lôo H.
    Encephale; 1993 May; 19(4):333-40. PubMed ID: 8275921
    [Abstract] [Full Text] [Related]

  • 30. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
    Honig A, Kuyper AM, Schene AH, van Melle JP, de Jonge P, Tulner DM, Schins A, Crijns HJ, Kuijpers PM, Vossen H, Lousberg R, Ormel J, MIND-IT investigators.
    Psychosom Med; 2007 May; 69(7):606-13. PubMed ID: 17846258
    [Abstract] [Full Text] [Related]

  • 31. Nefazodone in the treatment of severe, melancholic, and recurrent depression.
    Marcus RN, Mendels J.
    J Clin Psychiatry; 1996 May; 57 Suppl 2():19-23. PubMed ID: 8626359
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 33. Relapse prevention with gepirone ER in outpatients with major depression.
    Keller MB, Ruwe FJ, Janssens CJ, Sitsen JM, Jokinen R, Janczewski J.
    J Clin Psychopharmacol; 2005 Feb; 25(1):79-84. PubMed ID: 15643103
    [Abstract] [Full Text] [Related]

  • 34. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C, Olivieri L, Di Loreto G, Dionisio P.
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [Abstract] [Full Text] [Related]

  • 35. Paliperidone extended-release in schizoaffective disorder: a randomized, controlled study comparing a flexible dose with placebo in patients treated with and without antidepressants and/or mood stabilizers.
    Canuso CM, Schooler N, Carothers J, Turkoz I, Kosik-Gonzalez C, Bossie CA, Walling D, Lindenmayer JP.
    J Clin Psychopharmacol; 2010 Oct; 30(5):487-95. PubMed ID: 20814330
    [Abstract] [Full Text] [Related]

  • 36. Sertraline is more effective than imipramine in the treatment of non-melancholic depression: results from a multicentre, randomized study.
    Baca E, González de Chávez M, García-Toro M, Pérez-Arnau F, Porras-Chavarino A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):493-500. PubMed ID: 12691786
    [Abstract] [Full Text] [Related]

  • 37. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders.
    Baca E, Garcia-Garcia M, Porras-Chavarino A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):57-65. PubMed ID: 14687858
    [Abstract] [Full Text] [Related]

  • 38. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S, Volz HP, Möller HJ, Dienel A, Kieser M.
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
    [Abstract] [Full Text] [Related]

  • 39. Buspirone in depressed outpatients: a controlled study.
    Rickels K, Amsterdam J, Clary C, Hassman J, London J, Puzzuoli G, Schweizer E.
    Psychopharmacol Bull; 1990 Nov; 26(2):163-7. PubMed ID: 2236452
    [Abstract] [Full Text] [Related]

  • 40. Gepirone treatment of atypical depression: preliminary evidence of serotonergic involvement.
    McGrath PJ, Stewart JW, Quitkin FM, Wager S, Jenkins SW, Archibald DG, Stringfellow JC, Robinson DS.
    J Clin Psychopharmacol; 1994 Oct; 14(5):347-52. PubMed ID: 7806692
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.